Researcher

Pengfei Ren

Nanfang Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 7, 2026 · JOURNAL ARTICLE

Dietary alpha‐lipoic acid supplementation alleviates high‐fat diet‐induced hepatic steatosis and inflammation by remodeling the gut microbiota and restoring the primary bile acid pool

Journal of the Science of Food and Agriculture

This is a mechanistic study in a single animal model without human data, showing pathway elucidation rather than clinical evidence of efficacy or safety.

Hypothesis-GeneratingHui Qi Liver Disease Diagnosis and Treatment Pengfei Ren

Reported

Dose and duration60 mg/kg/d for 12 weeks

SpeciesC57BL/6 mice

AUG 11, 2026 · JOURNAL ARTICLE

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC

Frontiers in Immunology

Retrospective analysis across multiple cohorts showing associations between intratumoral heterogeneity and immunotherapy response and recurrence, but limited by observational design, lack of prospective validation, and surrogate endpoints rather than hard clinical outcomes.

PromisingRadiomics and Machine Learning in Medical Imaging Haofei Wang Yuhang Wang

Reported

Sample size (advanced NSCLC immun…504

Sample size (early-stage surgical…121

NGS testing panel scope (surgical…733-panel